Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 3
1960 1
1963 1
1964 5
1965 2
1971 1
1974 1
1977 1
1978 2
1979 1
1981 2
1982 3
1983 3
1984 6
1985 6
1986 5
1987 3
1988 3
1989 22
1990 9
1991 13
1992 10
1993 19
1994 13
1995 21
1996 26
1997 24
1998 23
1999 34
2000 27
2001 46
2002 48
2003 49
2004 61
2005 87
2006 103
2007 78
2008 119
2009 122
2010 121
2011 136
2012 147
2013 162
2014 179
2015 182
2016 174
2017 192
2018 184
2019 213
2020 228
2021 289
2022 298
2023 252
2024 271
2025 289
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,893 results

Results by year

Filters applied: . Clear all
Page 1
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Fayette J, Licitra L, Harrington K, Haddad R, Siu LL, Liu YC, Tahara M, Machiels JP, Rischin D, Seiwert TY, Ferris RL, Keilholz U, Psyrri A, Keam B, Bossi P, Metcalf R, Hsieh CY, Clement PMJ, Isaev P, Mudunov A, Dinis J, Hoeben A, Kasper S, Klinghammer K, Hwang M, Blando J, Serrano O, Ruscica D, Cohen RB; INTERLINK-1 investigators. Fayette J, et al. Among authors: liu yc. Clin Cancer Res. 2025 Jul 1;31(13):2617-2627. doi: 10.1158/1078-0432.CCR-25-0073. Clin Cancer Res. 2025. PMID: 40300079 Free PMC article. Clinical Trial.
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan.
Wu HY, Chang PH, Huang YS, Tsai CS, Chen KY, Lin IF, Hsih WH, Tsai WL, Chen JA, Yang TL, Lee CY, Ho TS, Wang HW, Huang SF, Wu AY, Chen HJ, Chen YC, Chen WC, Tseng CH, Lin PC, Yang CH, Hong PL, Lee SS, Chen YS, Liu YC, Wang FD; Infectious Disease Society of Taiwan,; Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education,; CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,; 7th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group. Wu HY, et al. Among authors: liu yc. J Microbiol Immunol Infect. 2023 Apr;56(2):207-235. doi: 10.1016/j.jmii.2022.12.003. Epub 2022 Dec 21. J Microbiol Immunol Infect. 2023. PMID: 36586743 Free PMC article. Review.
The ubiquitin system in immune regulation.
Park Y, Jin HS, Aki D, Lee J, Liu YC. Park Y, et al. Among authors: liu yc. Adv Immunol. 2014;124:17-66. doi: 10.1016/B978-0-12-800147-9.00002-9. Adv Immunol. 2014. PMID: 25175772 Review.
Vibrio vulnificus in Taiwan.
Hsueh PR, Lin CY, Tang HJ, Lee HC, Liu JW, Liu YC, Chuang YC. Hsueh PR, et al. Among authors: liu yc. Emerg Infect Dis. 2004 Aug;10(8):1363-8. doi: 10.3201/eid1008.040047. Emerg Infect Dis. 2004. PMID: 15496235 Free PMC article. Review.
Lycopodine-Type Alkaloids from Lycopodium japonicum.
He J, Wu XD, Liu F, Liu YC, Peng LY, Zhao Y, Cheng X, Luo HR, Zhao QS. He J, et al. Among authors: liu yc. Nat Prod Bioprospect. 2014 Aug;4(4):213-9. doi: 10.1007/s13659-014-0027-1. Epub 2014 Jul 17. Nat Prod Bioprospect. 2014. PMID: 25089239 Free PMC article.
3,893 results